PolTREG S.A. (PTG) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.154x

Based on the latest financial reports, PolTREG S.A. (PTG) has a cash flow conversion efficiency ratio of -0.154x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-7.63 Million ≈ $-2.10 Million USD) by net assets (zł49.48 Million ≈ $13.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

PolTREG S.A. - Cash Flow Conversion Efficiency Trend (2018–2024)

This chart illustrates how PolTREG S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PTG current and long-term liabilities for a breakdown of total debt and financial obligations.

PolTREG S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of PolTREG S.A. ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
TMK Energy Ltd
AU:TMK
-0.030x
Calgro M3 Holdings Ltd
JSE:CGR
-0.059x
Kidoz Inc
V:KIDZ
0.061x
Leyand International Tbk
JK:LAPD
0.140x
Termorex
WAR:TRR
-0.117x
JPEL Private Equity Ltd
LSE:JPEL
0.022x
Aneka Jaringan Holdings Bhd
KLSE:0226
-0.080x
Murudeshwar Ceramics Limited
NSE:MURUDCERA
0.023x

Annual Cash Flow Conversion Efficiency for PolTREG S.A. (2018–2024)

The table below shows the annual cash flow conversion efficiency of PolTREG S.A. from 2018 to 2024. For the full company profile with market capitalisation and key ratios, see PTG market cap.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 zł69.23 Million
≈ $19.05 Million
zł-16.00 Million
≈ $-4.40 Million
-0.231x -52.30%
2023-12-31 zł87.52 Million
≈ $24.09 Million
zł-13.28 Million
≈ $-3.66 Million
-0.152x -78.29%
2022-12-31 zł101.04 Million
≈ $27.81 Million
zł-8.60 Million
≈ $-2.37 Million
-0.085x -128.55%
2021-12-31 zł103.01 Million
≈ $28.35 Million
zł-3.84 Million
≈ $-1.06 Million
-0.037x +82.85%
2020-12-31 zł12.83 Million
≈ $3.53 Million
zł-2.79 Million
≈ $-767.30K
-0.217x -100.11%
2019-12-31 zł-6.00K
≈ $-1.65K
zł-1.19 Million
≈ $-327.51K
198.333x +14627.96%
2018-12-31 zł764.00K
≈ $210.26K
zł-1.04 Million
≈ $-287.05K
-1.365x --

About PolTREG S.A.

WAR:PTG Poland Biotechnology
Market Cap
$21.82 Million
zł79.28 Million PLN
Market Cap Rank
#24762 Global
#244 in Poland
Share Price
zł17.00
Change (1 day)
-0.87%
52-Week Range
zł16.50 - zł37.10
All Time High
zł72.40
About

Poltreg S.A., a biotechnology company, researches and develops therapies for autoimmune diseases. It engages in the development of therapies for the treatment of type 1 diabetes in children, as well as multiple sclerosis. The company was incorporated in 2016 and is based in Gdansk, Poland.